Metallic amphiphiles are used as
building blocks in the construction
of nanoscale superstructures, where the hydrophobic effects induce
the self-assembly of the nanoparticles of interest. However, the influence
of synergizing multiple chemical interactions on an effective design
of these structures mostly remains an open question. In this regard,
supraamphiphilic systems based on flexible surfactant molecules and
rigid macrocycles are being actively developed, but there are few
works on the interaction between metallosurfactants and macrocycles.
In the present work, the self-assembly and biological properties of
a metallosurfactant with calixarene were studied for the first time.
The metallosurfactant, a complex between lanthanum nitrate and two
4-aza-1-hexadecylazoniabicyclo[2.2.2]octane bromide units, and calix[4]resorcinol
containing sulfonate groups on the upper rim were used to form a novel
supraamphiphilic composition. The system formed was studied using
a variety of physicochemical methods, including spectrophotometry,
NMR, XRF, and dynamic and electrophoretic light scattering. It was
found that the most optimal tetraanionic calix[4]resorcinol to dicationic
metallosurfactant molar ratio, leading to mixed aggregation upon ion
pair complexation, is 2:3. The mixed aggregates formed in the pentamolar
concentration range were able to encapsulate hydrophilic substrates,
including the anticancer drug cisplatin, the pure form of which is
more cytotoxic toward healthy cells than toward diseased cells. Interestingly,
the drug loaded into the macrocycle–metallosurfactant particles
was less cytotoxic to a healthy Chang liver cell line and more cytotoxic
to tumor M-HeLa cells. This selectivity depends on the amount of cisplatin
added. The more drug is added to the macrocycle–metallosurfactant
composition, the greater the biological activity against cancer cells.
Taking into account that the appearance of resistance of cancer cells
to drugs, especially to cisplatin, is one of the most important problems
in treatment, the results of this work envisage the potential application
of a mixed macrocycle–metallosurfactant system for the design
of therapeutic cisplatin compositions.